Drug 'Slows Parkinson's Progression'

In a breakthrough research, a drug has been shown to be able to slow the progression of the Parkinson's disease.

According to preliminary study, early use of rasagiline, also known as Azilect, may be able to slow down progression of Parkinson's disease.

Parkinson’s Disease - Causes, Symptoms, Diagnosis, Treatment
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson’s disease are correctable to an extent.

The study found that patients who took the drug rasagiline soon after diagnosis had a less aggressive form of Parkinson's than those who did not take it until later.

The international study involved more than 1,000 patients, but doctors stress it could be 10 to 15 years before the long-term benefits become clear.

Details were presented at a neurological conference in Madrid.

Parkinson's Disease
Slide animation on Parkinson disease. It is a progressive movement disorder due to degeneration of nerve cells of the substantia nigra of the brain. The symptoms get worse with time but drugs or surgery can control them. PD cannot be cured.

Symptoms of the progressive neurological disorder include shakes, memory loss and stiffening of the muscles.

The researchers believe that the drug could work by creating a long lasting protection for brain cells.

Advertisements

Epilepsy Drug Shows Improvement in Parkinson Disease Patients
Researchers have observed a significant decrease in symptoms of Parkinson disease patients with use of a drug used to treat epilepsy.

Professor David Burn, from the University of Newcastle, one of the researchers who took part in the study described the results as "exciting".

"The data show that early treatment can result in a slowing of clinical progression. These data are also consistent with an earlier trial with rasagiline which showed a similar outcome," BBC quoted him, as saying.